Advertisement
Nearly half of Medicaid patients with chronic hepatitis C have been denied newer direct-acting antiviral medications

Expensive Hep C Drugs Denied to Almost Half of Medicaid Patients

0
Most common reason for denial was "insufficient information to assess medical need"
Portrazza (necitumumab)

FDA Approves Portrazza for Advanced Squamous NSCLC

0
Drug is designed to block activity of epidermal growth factor receptor protein
Too few Americans who are at risk for HIV infection are taking Truvada (emtricitabine and tenofovir disoproxil fumarate) -- a daily pill that could protect them against the virus

CDC: PrEP Rx Needs to Increase for Optimal HIV Prevention

0
Medication can prevent infection with the virus in people at high risk
Melatonin might improve sleep patterns for children with atopic dermatitis

Melatonin May Improve Sleep in Children With Atopic Dermatitis

0
Children taking melatonin fell asleep about 21 minutes sooner than those taking placebo
Clinicians prescribing methylphenidate for treatment of attention-deficit/hyperactivity disorder in children and teens must weigh the benefits and adverse effects in the context of low-quality evidence

Low-Quality Evidence for Methylphenidate in ADHD

0
Review highlights need for long-term, large, better-quality randomized trials
Between 2009 and 2015

Dermatologic Drug Prices Up Substantially From 2009

0
Findings for brand-name meds; generics also increased substantially from 2011 to 2014
Patients at VA hospitals who contracted Clostridium difficile following surgery were five times more likely to die and 12 times more likely to suffer postoperative morbidity

C. Difficile Infection Tied to Higher Risk of Post-Op Mortality

0
Postoperative complications also increased in this patient population
Physicians should prescribe generic medications whenever possible

ACP: Physicians Should Prescribe Generic Meds If Possible

0
Brand name medications not superior to molecularly identical generic medications
U.S. Food and Drug Administration approval for the BioThrax anthrax vaccine has been expanded to include adults aged 18 to 65 with known or suspected exposure

FDA Expands Anthrax Vaccine Approval

0
Now sanctioned for adults 18 to 65 with known or suspected exposure
Opdivo (nivolumab) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma.

FDA Approves Opdivo for Advanced Renal Cell Carcinoma

0
Drug works by targeting the PD-1/PD-L1 cellular pathway